UBS AM
CRHM

UBS AM’s CRH Medical Corporation CRHM Stock Holding History

UBS AM’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,100
Closed -$47K – 2618
2017
Q3 		$47K Buy
+18,100
New +$55.6K ﹤0.01% 2401

Other funds holding CRHM

Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM's CRHM Position: Q4 2017 in Review

UBS AM sold out of CRH Medical Corporation (CRHM) in Q4 2017, closing a stake of 18,100 shares — an estimated $47K sold.

UBS AM first reported a position in CRHM in Q3 2017 and held it in 1 quarter. The position peaked at $47K in Q3 2017. 40 funds tracked by Wall St. Rank hold CRHM as of Q4 2017.

  • UBS AM reported no remaining CRH Medical Corporation position as of Q4 2017 after selling out during the quarter.
  • UBS AM sold 18,100 CRH Medical Corporation shares in Q4 2017, an estimated $47K.
  • UBS AM first reported a position in CRH Medical Corporation in Q3 2017 and held it in 1 quarter.
  • UBS AM's CRH Medical Corporation position peaked at $47K in Q3 2017.
  • 40 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q4 2017.

Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.